Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chlorination-coupling method for alpha nucleosides. Reduces purification steps, improves selectivity for antisense drug manufacturing.
Patent CN120365338A reveals NBS-oxidized Mitsunobu reaction for nucleosides. Reduces toxic waste and cost. Reliable supplier for pharma intermediates.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.